Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
58,006,486
-
Shares change
-
+1,824,021
-
Total reported value, excl. options
-
$2,674,145,349
-
Value change
-
+$50,031,635
-
Put/Call ratio
-
37%
-
Number of buys
-
91
-
Number of sells
-
90
-
Price
-
$46.11
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q4 2018
As of 31 Dec 2018 AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) had 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 58,006,486 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., Capital International Investors, BB BIOTECH AG, PRICE T ROWE ASSOCIATES INC /MD/, Woodford Investment Management Ltd, STATE STREET CORP, and Clearbridge Investments, LLC.
This table shows 182 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.